TY - JOUR
T1 - Inhibitory effects of flavonoids extracted from Nepalese propolis on the LPS signaling pathway
AU - Funakoshi-Tago, Megumi
AU - Ohsawa, Kentaro
AU - Ishikawa, Toshiyuki
AU - Nakamura, Fumika
AU - Ueda, Fumihito
AU - Narukawa, Yuji
AU - Kiuchi, Fumiyuki
AU - Tamura, Hiroomi
AU - Tago, Kenji
AU - Kasahara, Tadashi
N1 - Funding Information:
This work was supported in part by grants ( 25460073 ) from MEXT , Uehara Memorial Foundation , TOBE MAKI Scholarship Foundation and Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research . This work was also supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Grant Number S1411004 ).
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Flavonoids, particularly those derived from plants, harbor biological effects such as anti-inflammation and the inhibition of cancer progression. In the present study, we investigated the effects of 10 kinds of flavonoids isolated from Nepalese propolis on the LPS signaling pathway in order to clarify their anti-inflammatory activities. Five types of flavonoids: isoliquiritigenin, chrysin, 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, and cearoin, markedly inhibited inflammatory responses including LPS-induced NO production by suppressing the expression of iNOS mRNA and LPS-induced mRNA expression of TNFα and CCL2. Their inhibitory effects on LPS-induced inflammatory responses correlated with the intensities of these flavonoids to suppress the LPS-induced activation of nuclear factor κB (NF-κB), an essential transcription factor for the mRNA expression of iNOS, TNFα, and CCL2. Among these flavonoids, 3′,4′-dihydroxy-4-methoxydalbergione and 4-methoxydalbergion markedly inhibited the LPS-induced activation of IKK, thereby abrogating the degradation of IκBα and nuclear localization of NF-κB. On the other hand, isoliquiritigenin, chrysin, and cearoin failed to inhibit these signaling steps, but suppressed the transcriptional activity of NF-κB, which caused their anti-inflammatory effects. The results of the present study revealed that these five kinds of flavonoids are the components of Nepalese propolis that exhibit anti-inflammatory activities with a different regulatory mechanism for the activation of NF-κB.
AB - Flavonoids, particularly those derived from plants, harbor biological effects such as anti-inflammation and the inhibition of cancer progression. In the present study, we investigated the effects of 10 kinds of flavonoids isolated from Nepalese propolis on the LPS signaling pathway in order to clarify their anti-inflammatory activities. Five types of flavonoids: isoliquiritigenin, chrysin, 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, and cearoin, markedly inhibited inflammatory responses including LPS-induced NO production by suppressing the expression of iNOS mRNA and LPS-induced mRNA expression of TNFα and CCL2. Their inhibitory effects on LPS-induced inflammatory responses correlated with the intensities of these flavonoids to suppress the LPS-induced activation of nuclear factor κB (NF-κB), an essential transcription factor for the mRNA expression of iNOS, TNFα, and CCL2. Among these flavonoids, 3′,4′-dihydroxy-4-methoxydalbergione and 4-methoxydalbergion markedly inhibited the LPS-induced activation of IKK, thereby abrogating the degradation of IκBα and nuclear localization of NF-κB. On the other hand, isoliquiritigenin, chrysin, and cearoin failed to inhibit these signaling steps, but suppressed the transcriptional activity of NF-κB, which caused their anti-inflammatory effects. The results of the present study revealed that these five kinds of flavonoids are the components of Nepalese propolis that exhibit anti-inflammatory activities with a different regulatory mechanism for the activation of NF-κB.
KW - Anti-inflammatory activity
KW - Flavonoid
KW - IKK
KW - LPS
KW - NF-κB
KW - Propolis
UR - http://www.scopus.com/inward/record.url?scp=84994753685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994753685&partnerID=8YFLogxK
U2 - 10.1016/j.intimp.2016.10.008
DO - 10.1016/j.intimp.2016.10.008
M3 - Article
C2 - 27770720
AN - SCOPUS:84994753685
SN - 1567-5769
VL - 40
SP - 550
EP - 560
JO - International Immunopharmacology
JF - International Immunopharmacology
ER -